Compare EDUC & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EDUC | BNGO |
|---|---|---|
| Founded | 1965 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Consumer Specialties | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.7M | 11.6M |
| IPO Year | 1995 | 2018 |
| Metric | EDUC | BNGO |
|---|---|---|
| Price | $1.32 | $1.20 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $6.33 |
| AVG Volume (30 Days) | 19.2K | ★ 217.1K |
| Earning Date | 01-08-2026 | 03-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 94.50 |
| EPS | ★ 0.63 | N/A |
| Revenue | ★ $34,191,000.00 | $12,000,735.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $24.27 |
| P/E Ratio | $2.11 | ★ N/A |
| Revenue Growth | N/A | ★ 26.26 |
| 52 Week Low | $0.92 | $1.06 |
| 52 Week High | $1.84 | $5.50 |
| Indicator | EDUC | BNGO |
|---|---|---|
| Relative Strength Index (RSI) | 44.39 | 50.69 |
| Support Level | $1.25 | $1.07 |
| Resistance Level | $1.35 | $1.64 |
| Average True Range (ATR) | 0.05 | 0.07 |
| MACD | -0.00 | 0.02 |
| Stochastic Oscillator | 28.00 | 28.95 |
Educational Development Corp is the United States trade publisher of the line of educational children's books produced in the United Kingdom. Its business activity functions with two reportable segments: PaperPie and Publishing. The Publishing Division segment markets its products to retail accounts, which include books, school supplies, toy and gift stores and museums, through commissioned sales representatives, trade and specialty wholesalers and an internal telesales group.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.